Sartorius Stedim Biotech SA Total Liabilities

Latest as of June 2026: €3.67 Billion EUR ≈ $4.29 Billion USD

Sartorius Stedim Biotech SA total liabilities. Based on the latest financial reports, Sartorius Stedim Biotech SA (DIM) has total liabilities worth €3.67 Billion EUR (≈ $4.29 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Sartorius Stedim Biotech SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Sartorius Stedim Biotech SA (2005–2025)

Total liabilities of Sartorius Stedim Biotech SA from 2005 to 2025. This chart illustrates how Sartorius Stedim Biotech SA's total liabilities have evolved over time, based on quarterly financial data. Check Sartorius Stedim Biotech SA (DIM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Sartorius Stedim Biotech SA Competitors by Total Liabilities

The table below lists competitors of Sartorius Stedim Biotech SA ranked by their total liabilities.

Company Country Total Liabilities
INTERCONT HOTELS
F:IC1B
Germany €7.58 Billion
Broadridge Financial Solutions Inc
NYSE:BR
USA $5.96 Billion
Jardine Matheson Holdings Limited
F:H4W
Germany €31.74 Billion
BANCO BRANDESCO SP.ADR 1
F:BREA
Germany €2.15 Trillion
Banco de Chile
F:G4RA
Germany €49.93 Trillion
SAIC Motor Corp Ltd
SHG:600104
China CN¥573.11 Billion
Amerize Inc.
SW:AMRZ
Switzerland CHF11.74 Billion
Woodward Inc
NASDAQ:WWD
USA $2.15 Billion

Liability Composition Analysis (2005–2025)

This chart breaks down Sartorius Stedim Biotech SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see DIM current and non-current assets.

Liquidity & Leverage Metrics

Sartorius Stedim Biotech SA Total Liabilities Ratios Explained

Sartorius Stedim Biotech SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.46 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sartorius Stedim Biotech SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sartorius Stedim Biotech SA (2005–2025)

The table below shows the annual total liabilities of Sartorius Stedim Biotech SA from 2005 to 2025.

Year Total Liabilities Change
2025-12-31 €3.89 Billion
≈ $4.55 Billion
-8.06%
2024-12-31 €4.23 Billion
≈ $4.95 Billion
-16.46%
2023-12-31 €5.07 Billion
≈ $5.92 Billion
+98.60%
2022-12-31 €2.55 Billion
≈ $2.98 Billion
+15.03%
2021-12-31 €2.22 Billion
≈ $2.59 Billion
+39.80%
2020-12-31 €1.59 Billion
≈ $1.85 Billion
+146.80%
2019-12-31 €642.79 Million
≈ $751.49 Million
+22.07%
2018-12-31 €526.59 Million
≈ $615.64 Million
+0.41%
2017-12-31 €524.45 Million
≈ $613.14 Million
+21.32%
2016-12-31 €432.29 Million
≈ $505.40 Million
+3.19%
2015-12-31 €418.92 Million
≈ $489.76 Million
+13.76%
2014-12-31 €368.25 Million
≈ $430.52 Million
-5.43%
2013-12-31 €389.39 Million
≈ $455.24 Million
+8.42%
2012-12-31 €359.14 Million
≈ $419.88 Million
+10.49%
2011-12-31 €325.04 Million
≈ $380.00 Million
+11.59%
2010-12-31 €291.27 Million
≈ $340.52 Million
+6.05%
2009-12-31 €274.66 Million
≈ $321.10 Million
-2.15%
2008-12-31 €280.70 Million
≈ $328.16 Million
+0.98%
2007-12-31 €277.96 Million
≈ $324.97 Million
+33.37%
2006-12-31 €208.41 Million
≈ $243.65 Million
-2.69%
2005-12-31 €214.18 Million
≈ $250.39 Million
--

About Sartorius Stedim Biotech SA

PA:DIM France Medical Instruments & Supplies
Market Cap
$25.23 Billion
€21.58 Billion EUR
Market Cap Rank
#1367 Global
#32 in France
Share Price
€221.80
Change (1 day)
+2.31%
52-Week Range
€151.50 - €223.00
All Time High
€542.33
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more